Cytoplasmic expression of the JM403 antigen GlcA-GlcNH 3 + on heparan sulfate glycosaminoglycan in mammary carcinomas-a novel proliferative biomarker for breast cancers with high malignancy

Glycoconjugate Journal

Volumn 27, Issue 7-9, 2010, Pages 661-672

  Fujii, Masahiro ^a,b   Yusa, Akiko ^a   Yokoyama, Yukihiro ^b   Kokuryo, Toshio ^b   Tsunoda, Nobuyuki ^b   Oda, Koji ^a,b   Nagino, Masato ^b   Ishimaru, Tsuyoshi ^c   Shimoyama, Yoshie ^d   Utsunomiya, Hirotoshi ^e   Iwata, Hiroji ^a   Itoh, Yoshiko ^f   Itoh, Johbu ^f   Kannagi, Reiji ^a   Kyogashima, Mamoru ^a,g  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Seikagaku Biobusiness Corporation   (Japan)

^d NAGOYA UNIVERSITY HOSPITAL   (Japan)

^e WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^f TOKAI UNIVERSITY   (Japan)

^g NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Biomarker; Breast cancer; Heparan sulfate glycosaminoglycan; JM403; Ki67 labeling index

Indexed keywords

EPITOPE; GLUCOSAMINE DERIVATIVE; GLUCURONIC ACID; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY JM403; N SUBSTITUTED GLUCOSAMINE; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CELL; CANCER GRADING; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MITOSIS RATE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL PROLIFERATION; CYTOPLASM; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; INTESTINE, SMALL; KI-67 ANTIGEN; MAMMARY GLANDS, HUMAN; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 78651244716     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-010-9311-4     Document Type: Article

References (33)

1. R Kannagi S Hakomori 2001 A guide to monoclonal antibodies directed to glycotopes Adv. Exp. Med. Biol. 491 587 630 1:CAS:528:DC%2BD3sXns1aqtbc%3D 14533823
2. R Kannagi M Izawa T Koike K Miyazaki N Kimura 2004 Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis Cancer Sci. 95 377 384 1:CAS:528:DC%2BD2cXltlaitLs%3D 10.1111/j.1349-7006.2004.tb03219.x 15132763 (Pubitemid 38832679)
3. R Sasisekharan Z Shriver G Venkataraman U Narayanasami 2002 Roles of heparan-sulphate glycosaminoglycans in cancer Nat. Rev. Cancer 2 521 528 1:CAS:528:DC%2BD38XkvFKltLY%3D 10.1038/nrc842 12094238
4. CY Koo BH Bay PC Lui GM Tse PH Tan GW Yip 2006 Immunohistochemical expression of heparan sulfate correlates with stromal cell proliferation in breast phyllodes tumors Mod. Pathol. 19 1344 1350 1:CAS:528:DC%2BD28Xps1yjsr8%3D 10.1038/modpathol.3800657 16862076 (Pubitemid 44423082)
5. MJ Stanley MW Stanley RD Sanderson R Zera 1999 Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma Am. J. Clin. Pathol. 112 377 83 1:CAS:528:DyaK1MXlvFWisLs%3D 10478144
6. K Matsuda H Maruyama F Guo J Kleeff J Itakura Y Matsumoto AD Lander M Korc 2001 Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells Cancer Res. 61 5562 5569 1:CAS:528:DC%2BD3MXlsVChsbY%3D 11454708
7. N Yamauchi A Watanabe M Hishinuma K Ohashi Y Midorikawa Y Morishita T Niki J Shibahara M Mori M Makuuchi Y Hippo T Kodama H Iwanari H Aburatani M Fukayama 2005 The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma Mod. Pathol. 18 1591 1598 1:CAS:528: DC%2BD2MXht1aru7nE 15920546
8. XY Wang F Degos S Dubois S Tessiore M Allegretta RD Guttmann S Jothy J Belghiti P Bedossa V Paradis 2006 Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas Hum. Pathol. 37 1435 1441 1:CAS:528:DC%2BD28XhtFSrt7nP 10.1016/j.humpath.2006. 05.016 16949914 (Pubitemid 44739946)
9. M Götte GW Yip 2006 Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective Cancer Res. 66 10233 10237 10.1158/0008-5472.CAN- 06-1464 17079438 (Pubitemid 44799736)
10. EA McKenzie 2007 Heparanase: a target for drug discovery in cancer and inflammation Br. J. Pharmacol. 151 1 14 1:CAS:528:DC%2BD2sXkslClsrc%3D 10.1038/sj.bjp.0707182 17339837 (Pubitemid 46675998)
11. J Kreuger D Spillmann JP Li U Lindahl 2006 Interactions between heparan sulfate and proteins: the concept of specificity J. Cell Biol. 174 323 327 1:CAS:528:DC%2BD28XnvF2htr0%3D 10.1083/jcb.200604035 16880267 (Pubitemid 44156762)
12. JR Bishop M Schuksz JD Esko 2007 Heparan sulphate proteoglycans fine-tune mammalian physiology Nature 446 1030 1037 1:CAS:528:DC%2BD2sXksFersrw%3D 10.1038/nature05817 17460664 (Pubitemid 46676065)
13. J Jang-Lee SJ North M Sutton-Smith D Goldberg M Panico H Morris S Haslam A Dell 2006 Glycomic profiling of cells and tissues by mass spectrometry: fingerprinting and sequencing methodologies Methods Enzymol. 415 59 86 1:CAS:528:DC%2BD1cXhs1OmsLY%3D 10.1016/S0076-6879(06)15005-3 17116468 (Pubitemid 44751091)
14. J Hirabayashi 2008 Concept, strategy and realization of lectin-based glycan profiling J. Biochem. 144 139 147 1:CAS:528:DC%2BD1cXhtVyrsrjE 10.1093/jb/mvn043 18390573
15. S Ashikari-Hada H Habuchi Y Kariya N Itoh AH Reddi K Kimata 2004 Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library J. Biol. Chem. 279 12346 12354 1:CAS:528:DC%2BD2cXitl2gs78%3D 10.1074/jbc.M313523200 14707131 (Pubitemid 38445801)
16. N Ferrara 2004 Vascular endothelial growth factor: basic science and clinical progress Endocr. Rev 25 581 611 1:CAS:528:DC%2BD2cXns1Ght74%3D 10.1210/er.2003-0027 15294883 (Pubitemid 39099316)
17. D Mauri NP Polyzos G Salanti N Pavlidis JP Ioannidis 2008 Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer J. Natl. Cancer Inst. 100 1780 1791 1:CAS:528: DC%2BD1MXhtVGksA%3D%3D 10.1093/jnci/djn414 19066278
18. The Japanese Breast Cancer Society 2005 Histological classification Breast Cancer 12 S12 S14 10.1007/BF02973953
19. H Tsuda F Akiyama M Kurosumi G Sakamoto T Watanabe 1998 Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy Jpn. J. Clin. Oncol. 28 486 491 1:STN:280:DyaK1cvktF2iug%3D%3D 10.1093/jjco/28.8.486 9769782
20. J van den Born K Gunnarsson MA Bakker L Kjellén M Kusche-Gullberg M Maccarana JH Berden U Lindahl 1995 Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody J. Biol. Chem. 270 31303 31309 10.1074/jbc.270.52.31303 8537400 (Pubitemid 26012220)
21. G David XM Bai B Van der Schueren JJ Cassiman H Van den Berghe 1992 Developmental changes in heparan sulfate expression: in situ detection with mAbs J. Cell. Biol. 119 961 975 1:CAS:528:DyaK38XmtlSrt7Y%3D 10.1083/jcb.119.4.961 1385449
22. K Suzuki K Yamamoto Y Kariya H Maeda T Ishimaru S Miyaura M Fujii A Yusa EJ Joo K Kimata R Kannagi YS Kim M Kyogashima 2008 Generation and characterization of a series of monoclonal antibodies that specifically recognize [HexA(+/-2 S)-GlcNAc]n epitopes in heparan sulfate Glycoconj. J. 25 703 712 1:CAS:528:DC%2BD1cXht1equrfJ 10.1007/s10719-008-9130-z 18461440
23. G Cattoretti MH Becker G Key M Duchrow C Schlüter J Galle J Gerdes 1992 Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections J. Pathol. 168 357 363 1:CAS:528:DyaK3sXhsVartLc%3D 10.1002/path.1711680404 1484317 (Pubitemid 23013251)
24. S Ghosh CA Sullivan MP Zerkowski AM Molinaro DL Rimm RL Camp GG Chung 2008 High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer Hum. Pathol. 39 1835 1843 1:CAS:528:DC%2BD1cXhtlyltbzK 10.1016/j.humpath.2008.06.004 18715621
25. SO Kolset H Tveit 2008 Serglycin-structure and biology Cell. Mol. Life Sci. 65 1073 1085 1:CAS:528:DC%2BD1cXkvFyns70%3D 10.1007/s00018-007-7455-6 18066495
26. C Westling U Lindahl 2002 Location of N-unsubstituted glucosamine residues in heparan sulfate J. Biol. Chem. 277 49247 49255 1:CAS:528: DC%2BD38XpsFalurY%3D 10.1074/jbc.M209139200 12374790 (Pubitemid 36018720)
27. JA Martellini AL Cole N Venkataraman GA Quinn P Svoboda BK Gangrade J Pohl OE Sørensen AM Cole 2009 Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma FASEB J. 23 3609 3618 1:CAS:528:DC%2BD1MXht1Gjtb7J 10.1096/fj.09-131961 19487309
28. A Gugliucci 2004 Polyamines as clinical laboratory tools Clin. Chim. Acta. 344 23 35 1:CAS:528:DC%2BD2cXktVOnsro%3D 10.1016/j.cccn.2004.02.022 15149868 (Pubitemid 38626134)
29. Hirabayashi, Y., Igarashi, Y., Merrill Jr., A.H.: Sphingolipids synthesis, transport and cellular signaling. In: Hirabayashi, Y., et al. (eds.) Sphingolipid biology, pp. 3-22. Springer, Tokyo (2006)
30. J van den Born K Salmivirta T Henttinen N Ostman T Ishimaru S Miyaura K Yoshida M Salmivirta 2005 Novel heparan sulfate structures revealed by monoclonal antibodies J. Biol. Chem. 280 20516 20523 10.1074/jbc.M502065200 15778504 (Pubitemid 40776752)
31. A Goldhirsch JN Ingle RD Gelber AS Coates B Thürlimann HJ Senn 2009 Panel members: Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 Ann. Oncol. 20 1319 1329 1:STN:280:DC%2BD1Mrjtlyhug%3D%3D 10.1093/annonc/mdp322 19535820
32. P Jalava T Kuopio L Juntti-Patinen T Kotkansalo P Kronqvist Y Collan 2006 Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index Histopathology 48 674 682 1:STN:280:DC%2BD283lslOqsQ%3D%3D 10.1111/j.1365-2559.2006.02402.x 16681683
33. A Urruticoechea IE Smith M Dowsett 2005 Proliferation marker Ki-67 in early breast cancer J. Clin. Oncol. 23 7212 7220 1:CAS:528:DC%2BD2MXhtFCrsbfK 10.1200/JCO.2005.07.501 16192605